InvestorsHub Logo
Followers 16
Posts 2090
Boards Moderated 0
Alias Born 01/28/2006

Re: None

Wednesday, 11/29/2006 1:31:25 PM

Wednesday, November 29, 2006 1:31:25 PM

Post# of 48
Nice news today:

VRDE (.037) New Antiseptic and Disinfectant Consumer Product Line on Retail Shelves - Initial Orders of $450,000 Delivered

Business Wire "US Press Releases "

LARGO, Fla.--(BUSINESS WIRE)--

Veridien Corporation (OTCBB:VRDE), through its wholly owned Canadian subsidiary Viraguard Canada Inc., has launched its Viraguard(R) consumer antiseptic and disinfectant product line in over 434 Canadian retail stores. Viraguard(R)'s patented technology platform allows it to deliver effective levels of disinfecting power making this a unique product line for consumers looking for a complete kit of household goods that helps enhance their family's cleansing, sanitizing and disinfecting routine.

The Viraguard(R) product line is now available on the shelves of Canadian retailers including Loblaws and Lawtons Drugstores. Both retailers are carrying the full Viraguard(R) consumer product line which includes seven (7) SKUs:

Viraguard(R) Antiseptic Hand Spray (unscented) - 250ml/8oz;

Viraguard(R) Antiseptic Hand Spray (green apple) - 250ml/8oz;

Viraguard(R) Antiseptic Hand Spray (green apple) - 3 pack of 60ml/2oz;

Viraguard(R) Antiseptic Hand Wipes (lemon) - 20 count;

Viraguard(R) Surface Hospital Disinfectant Spray (unscented) - 250ml/8oz;

Viraguard(R) Surface Hospital Disinfectant Wipes (unscented) - 40 count; and

Viraguard(R) Family Health Kit (250ml/8oz antiseptic hand spray + 20 count antiseptic hand wipes + 250ml/8oz surface hospital disinfectant spray).

Initial orders from these retailers in excess of $500,000 CDN (approx. $450,000 USD) have already been shipped. Veridien is committed to growing its Viraguard(R) franchise and is currently working on a number of strategies that are intended to expand its presence in both the retail and institutional sectors of the Canadian and US markets.

The Company has initiated a family health program that is focused on raising public awareness about the benefits of integrating antiseptics and disinfectants as part of a consumer's cleansing routine, appropriately positioned as CLEAN HANDS + CLEAN HOUSE = FAMILY HEALTH. The Viraguard(R) products have been shown to be effective against a host of bacteria, viruses and other pathogens that have been known to compromise immunity and lead to debilitating diseases.

The Viraguard(R) infection control product line is available to health practitioners and industrial material managers through major distributors across the United States.

"Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995

Forward-looking statements in this press release (identifiable by such words as "believes", "expects", "planned") are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, funding availability, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements.

About Veridien Corporation

For more information about Veridien Corporation and it investments in future technology, please visit: www.veridien.com and www.mycosol.com.

Source: Veridien Corporation

All posts are purely my opinion and are not buy or sell recommendations.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.